Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy

25Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Cancer is a disease that induces many local and systemic changes in immunity. The difficult nature of ovarian cancer stems from the lack of characteristic symptoms that contributes to a delayed diagnosis and treatment. Despite the enormous progress in immunotherapy, its efficacy remains limited. The heterogeneity of tumors, lack of diagnostic biomarkers, and complex immune landscape are the main challenges in the treatment of ovarian cancer. Integrative approaches that combine the tumor microenvironment – local immunity – together with periphery – systemic immunity – are urgently needed to improve the understanding of the disease and the efficacy of treatment. In fact, multiparametric analyses are poised to improve our understanding of ovarian tumor immunology. We outline an integrative approach including local and systemic immunity in ovarian cancer. Understanding the nature of both localized and systemic immune responses will be crucial to boosting the efficacy of immunotherapies in ovarian cancer patients.

Cite

CITATION STYLE

APA

Rajtak, A., Ostrowska-Leśko, M., Żak, K., Tarkowski, R., Kotarski, J., & Okła, K. (2022, November 10). Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2022.1018256

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free